NCT05954910 2026-02-02A Study to Evaluate the Effectiveness and Safety of Polatuzumab in Real World Clinical Practice Among Adult Chinese Participants With Diffuse Large B-Cell LymphomaHoffmann-La RocheActive not recruiting1,000 enrolled